Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Ketamine HCl Prolonged Release Oral Tablets for CRPS [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating prolonged-release oral ketamine hydrochloride tablets for complex regional pain syndrome; the trial is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine HCl prolonged-release oral tablets (ketamine hydrochloride prolonged-release oral tablet)

Snippet

Sponsor: University of Southern California | Conditions: Complex Regional Pain Syndromes | Phase 2 | Status: NOT_YET_RECRUITING